Jean-Baptiste Woillard selected to receive the 2020 IFCC-Gérard Siest Young Scientist Award

The INSERM U1248 IPPRITT is glad to announce the selection of Dr. Jean-Baptiste Woilllard to receive the 2020 IFCC-Gérard Siest Young Scientist Award for his distinguished contributions in Pharmacogenetics. More informations can be found here IFCC is the leading organization in the field of [...]

Prof. Pierre Marquet (Head of INSERM U1248 IPPRITT) elected to be Chair of EACPT

On June 7th 2019, Prof. Pierre Marquet (Head of the INSERM U1248) has been elected to be President of EACPT (European Association for Clinical Pharmacology and Therapeutics), within the executive committee. He will be appointed for 6 years, (Chair – 2019-2021, Chairperson – [...]

First structural elucidation of the human ABCC4/MRP4 exporter in lipid bilayers

The ABCC4/MRP4 exporter has a clinical impact on membrane transport of a broad range of xenobiotics. It is expressed at key locations for drug disposition or effects such as in the liver, the kidney and blood cells. Several polymorphisms and mutations (e.g., p.Gly187Trp) leading to MRP4 [...]

Review: Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose

Due to a high inter-individual variability in its pharmacokinetics, tacrolimus dose individualization is mandatory. Even though the expert opinion has defined the area under the curve (AUC) as the best marker to use when performing dose adjustment of tacrolimus, most centres only use trough [...]

Roland Lawson récompensé pour la pédagogie en ligne

À l’occasion du 22e congrès annuel de la Société Française de Pharmacologie et de Thérapeutique(SFPT), Roland Lawson (post-doctorant chargé de cours de pharmacologie à la faculté de Pharmacie) a obtenu le prix du meilleur poster modéré de la session pharmacovigilance. Le travail présenté [...]

Previous Next

Univ. Limoges News

INSERM News

Tous les événements

News

 21 novembre 2019 

IPPRITT Weekly Seminar

 4 juillet 2019 

IPPRITT – Summer Event

 19 décembre 2018 

Raclette du Labo

 18 décembre 2018 

PhD Defense of Benjamin Chantemargue

Organ transplantation repairs broken human being. It is among the most promising techniques to repair any single damaged part of a body in the near future. The INSERM U1248 IPPRITT unit is part of the hospital-university “Survival oPtimization in ORgan Transplantation” (FHU SUPORT) federation.

Owing to its translational research strategy, as led by clinicians, biologists, pharmacologists and physical-chemists, IPPRITT has developed both basic and clinical research programmes and tools to improve transplant patient care. The findings (mainly in pharmacology) are transferred to the clinics, aiming at the development of personalized medicine.